Balance Sheet

Cash Flow Statement

Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Cerus (CERS) Asset Writedowns and Impairment (2022 - 2023)

Cerus' Asset Writedowns and Impairment history spans 2 years, with the latest figure at $1.5 million for Q3 2023.

On a quarterly basis, Asset Writedowns and Impairment changed N/A to $1.5 million in Q3 2023 year-over-year; TTM through Dec 2023 was $951000.0, a N/A change, with the full-year FY2023 number at $1.7 million, changed N/A from a year prior.
Asset Writedowns and Impairment hit $1.5 million in Q3 2023 for Cerus, up from -$542000.0 in the prior quarter.
Over the last five years, Asset Writedowns and Impairment for CERS hit a ceiling of $1.5 million in Q3 2023 and a floor of -$542000.0 in Q4 2022.